Latest Updates
Research, FDA news, and clinical trial results for retatrutide and next-gen GLP-1 drugs.
Retatrutide FDA Approval Status (February 2026): Phase 3 Results & Expected Launch Date
Latest FDA approval update for retatrutide. See Phase 3 trial results, expected 2027-2028 launch timeline, and how the 24% weight loss breakthrough compares to Mounjaro and Wegovy.
Retatrutide vs Tirzepatide (Mounjaro): Which GLP-1 Wins for Weight Loss?
Head-to-head: Retatrutide delivers 24% weight loss vs Tirzepatide's 22% in clinical trials. See the dosing differences, side effect profiles, and cost projections.
Can You Buy Retatrutide in 2026? (Straight Answer + Legal Alternatives)
No—retatrutide isn't FDA-approved yet and can't be legally purchased in the U.S. until 2027-2028. See why gray market sources are risky and which proven alternatives exist today.
Ultimate TrumpRx Guide: Save 70% on GLP-1 Weight Loss Drugs
How to use TrumpRx.gov to slash GLP-1 costs: $50 flat copay on Wegovy ($1,349 → $50) and Zepbound ($1,088 → $50). Includes eligibility requirements and pharmacy workarounds.
Retatrutide for Knee Pain: Why the TRIUMPH-4 Results Are a Game-Changer
TRIUMPH-4 trial results show retatrutide reduced knee pain in patients with osteoarthritis—opening new treatment pathways beyond weight loss.
Can Retatrutide Reverse Fatty Liver? Analyzing the 80% Fat Reduction Results
Breakthrough Phase 3 results show 80% reduction in liver fat for NASH patients. See what this means for fatty liver disease treatment.
What Is Retatrutide? Next-Gen GLP-1 Triple Agonist Explained
Retatrutide explained: how this triple-receptor GLP-1 drug (GLP-1/GIP/glucagon) delivers 24% weight loss—2% more than Zepbound.
9 Best Places to Buy Semaglutide & Tirzepatide Online (2026 Comparison)
Compare top telehealth GLP-1 providers: Medvi ($179/mo), Ro ($149/mo), Hims, and 6 others. See pricing, doctor quality, and shipping speed.